BioSpace News Archive

NGM Biopharmaceuticals, Inc., a clinical-stage biotechnology company focused on discovering and developing transformative therapeutics for patients, provided business highlights and reported financial results for the quarterly period ended June 30, 2022.

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and six months ended June 30, 2022.

Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended June 30, 2022 (“the second quarter of 2022”) as compared to the three-month period ended June 30, 2021 (“the second quarter of 2021” or “the prior year period”).

OPKO Health, Inc. reports business highlights and financial results for the three and six months ended June 30, 2022.

Cognition Therapeutics, Inc. announced that Mary Hamby, Ph.D., vice president of research, presented results at the at Alzheimer’s Association International Conference of proteomic analysis of clinical biomarker data from the SPARC study of oral once-daily treatment with CT1812 in mild-to-moderate Alzheimer’s disease.

Gritstone bio, Inc., a clinical-stage biotechnology company working to develop the world’s most potent vaccines, reported financial results for the second quarter ended June 30, 2022 and reviewed business highlights.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, reported financial results for the three and six months ended June 30, 2022.

Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, reported financial results for the quarter ended June 30, 2022, and provided a business update.

Calyxt, Inc., a plant-based synthetic biology company, announced financial results for its second quarter ended June 30, 2022.

Amgen announced financial results for the second quarter of 2022.